Literature DB >> 1246015

Influence of prostaglandins E, A and F on vasoconstrictor responses to norepinephrine, renal nerve stimulation and angiotensin in the feline kidney.

B M Chapnick, P W Paustian, E Klainer, P D Joiner, A L Hyman, P J Kadowitz.   

Abstract

The effects of intrarenal infusion of prostaglandins (PGs) of the E, A and F series on renal vascular resistance and on vasoconstrictor responses to renal nerve stimulation (RNS), norepinephrine (NE) and angiotensin (A) were determined in the in situ feline kidney under conditions of controlled blood flow. Infusion of PGE2 (3 and 0.3 mug/min) and PGE1 (3 mug/min) resulted in a marked decrease in renal perfusion pressure and a reduction in responses to all vasoconstrictor stimuli. PGE2 (0.03 mug/min) did not alter perfusion pressure. However, responses to RNS and A but not to NE were attenuated. PGA2 (3 and 0.3 mug/min) had no significant effect on perfusion pressure. PGA1 (3 mug/min) resulted in a transient decrease in renal vascular resistance which was not maintained during the infusion period. PGA2 (3 mug/min) reduced the response to RNS at 10 and 30 cps and reduced the response to A, whereas responses to NE were not affected. PGA2 (0.3 mug/min) had no effect on responses to either of the pressor stimuli. PGA1 infusion resulted in an enhanced response to RNS at the highest stimulus frequency and decreased the response elicited by A. PGF2alpha (3 mug/min) had no significant effect on renal vascular resistance or on responses to NE and nerve stimulation. However, the response to angiotensin was decreased and responses to RNS at 10 and 30 cps were decreased 30 minutes after the PGF2alpha infusion. The present data demonstrate that, of the natural renal PGs, PGE2 and PGA2 possess the capacity to modulate the effects of the sympathetic nervous system on the feline kidney. In addition, the effects of PGE and PGA on responses to adrenergic stimuli and on vascular resistance could be separated.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1246015

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Prostaglandin actions on the adrenergic nervous system.

Authors:  H G Güllner
Journal:  Klin Wochenschr       Date:  1983-06-01

2.  Synthesis of 13,14-dehydroprostacyclin methyl ester: a potent inhibitor of platelet aggregation.

Authors:  J Fried; J Barton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

Review 3.  Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors.

Authors:  A E Farah; F Rosenberg
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

4.  PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice.

Authors:  Ying Sun; Zhanjun Jia; Gang Liu; Li Zhou; Mi Liu; Baoxue Yang; Tianxin Yang
Journal:  PPAR Res       Date:  2013-12-30       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.